Vaxart, Inc. Stock Issued During Period, Shares, Reverse Stock Splits
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Vaxart, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2018-12-31 was 0.00 shares.
- Vaxart, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2018-09-30 was 0.00 shares.
- Vaxart, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2018-06-30 was 0.00 shares.
- Vaxart, Inc. stock issued during period, shares, reverse stock splits for the quarter ending 2018-03-31 was 7.10M shares.
- Vaxart, Inc. stock issued during period, shares, reverse stock splits for fiscal 2018 was 7.10M shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits 3 month | Stock Issued During Period, Shares, Reverse Stock Splits 12 month |
|---|---|---|
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | 7.10M shares 10-K · filed 2019-02-06 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | |
| 2018-03-31 | 7.10M shares 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |